The Val432Leu polymorphism of the CYP1B1 gene is associated with differences in estrogen metabolism and bone density

Autor: Napoli, N, RINI, Giovam Battista, Serber, D, Giri, T, Yarramaneni, J, BUCCHIERI, Salvatore, CAMARDA, Lawrence, DI FEDE, Gaetana, CAMARDA, Rosolino, Jain, S, Mumm, S, Armamento Villareal, R.

Polymorphisms of the CYP450 genes that encode for the enzymes that metabolize estrogen are linked to hormone-related cancers. We investigated the impact of two polymorphisms of the CYP1B1 gene previously reported to be associated with hormone-related

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3658::07f57253669679284a740c130a85bef5
http://hdl.handle.net/10447/36386

ARID1A Mutations in Gastric Cancer: A Review with Focus on Clinicopathological Features, Molecular Background and Diagnostic Interpretation.

Autor: Angelico, Giuseppe¹ (AUTHOR) giuangel86@hotmail.it, Attanasio, Giulio² (AUTHOR) giulioatta@gmail.com, Colarossi, Lorenzo³ (AUTHOR) lorenzo.colarossi@grupposamed.com, Colarossi, Cristina³ (AUTHOR) cristina.colarossi@grupposamed.com, Montalbano, Matteo^3,4 (AUTHOR) eleonora.aiello@grupposamed.com, Aiello, Eleonora³ (AUTHOR), Di Vendra, Federica⁵ (AUTHOR), Mare, Marzia⁶ (AUTHOR), Orsi, Nicolas⁷ (AUTHOR) n.m.orsi@leeds.ac.uk, Memeo, Lorenzo³ (AUTHOR) lorenzo.memeo@grupposamed.com

Publikováno v: Cancers. Jun2024, Vol. 16 Issue 11, p2062. 14p.

Oncogenic Pathways and Targeted Therapies in Ovarian Cancer.

Autor: Lliberos, Carolina^1,2 (AUTHOR) carolina.lliberos@monash.edu, Richardson, Gary² (AUTHOR) gary.richardson@cabrini.com.au, Papa, Antonella¹ (AUTHOR) gary.richardson@cabrini.com.au

Publikováno v: Biomolecules (2218-273X). May2024, Vol. 14 Issue 5, p585. 24p.

PLAU promotes growth and attenuates cisplatin chemosensitivity in ARID1A-depleted non-small cell lung cancer through interaction with TM4SF1.

Autor: Zheng, Yuanliang¹ (AUTHOR), Zhang, Lixiang¹ (AUTHOR), Zhang, Kangliang² (AUTHOR), Wu, Shenghao³ (AUTHOR), Wang, Chichao¹ (AUTHOR), Huang, Risheng¹ (AUTHOR) hrs9900@wmu.edu.cn, Liao, Hongli⁴ (AUTHOR) hongliliao1@163.com

Publikováno v: Biology Direct. 1/17/2024, Vol. 19 Issue 1, p1-14. 14p.

Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling.

Autor: Chandler RL; 1] Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA [2] Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA., Damrauer JS; 1] Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA [2] Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA., Raab JR; 1] Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA [2] Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA., Schisler JC; 1] McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA [2] Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA., Wilkerson MD; 1] Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA [2] Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA., Didion JP; 1] Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA [2] Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA., Starmer J; 1] Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA [2] Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA., Serber D; 1] Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA [2] Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA., Yee D; 1] Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA [2] Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA., Xiong J; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA., Darr DB; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA., Pardo-Manuel de Villena F; 1] Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA [2] Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA., Kim WY; 1] Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA [2] Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA [3] Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA., Magnuson T; 1] Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA [2] Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.

Publikováno v: Nature communications [Nat Commun] 2015 Jan 27; Vol. 6, pp. 6118. Date of Electronic Publication: 2015 Jan 27.